Italia markets closed

Coloplast A/S (CLPBF)

Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a watchlist
119,370,00 (0,00%)
Alla chiusura: 09:30AM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente119,37
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno119,37 - 119,37
Intervallo di 52 settimane95,75 - 180,66
Media Volume153
Beta (5 anni mensile)0,27
Rapporto PE (ttm)38,76
EPS (ttm)3,08
Prossima data utiliN/D
Rendimento e dividendo (forward)2,83 (2,37%)
Data ex dividendo09 mag 2022
Stima target 1A18,37
  • GlobeNewswire

    Coloplast A/S - Announcement no. 14/2022 - Articles of Association

    Articles of Association for Coloplast A/S as adopted at the Annual General Meeting of Coloplast A/S held today, 1 December 2022 are enclosed. Our mission Making life easier for people with intimate health care needs Our values Closeness... to better understand Passion... to make a difference Respect and responsibility... to guide us Our vision Setting the global standard for listening and responding For further information, please contact Investors and analystsAnders Lonning-SkovgaardExecutive V

  • GlobeNewswire

    Coloplast A/S - Announcement no. 13/2022 - Decisions at the Annual General Meeting 2022

    Today, 1 December 2022, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The proposal on preparation, etc. of the annual report, company announcements and documents for the internal use by the general meeting in English was approved.The annual report for the financial year 2021/22 was approved.Distribution of year-end dividend of DKK 15.00 per share of nominally DKK 1 was approved. In addition to the interim dividend of DKK 5.00 per share of nominal

  • GlobeNewswire

    Coloplast Launches New Catheter in the U.S.

    Coloplast’s SpeediCath® Flex Set catheter developed for people living with bladder and urinary problems is now cleared in the U.S. and will be launched in November 2022. The new SpeediCath Flex Set with a “no touch dry sleeve” and an omni-directional tip is available as a catheter and bag solution, also called a Closed System. All SpeediCath® catheters feature Triple Action Coating Technology which is designed to reduce the risk of urethral damage and Urinary Tract Infections (UTIs)*1 and are an